INTRODUCTION {#S1}
============

Continuous circulation of the homeostatic naïve lymphocyte population through lymph nodes (LNs) is a central tenet of immune surveillance. Cellular entry into and exit from these LNs are at equilibrium in the absence of overt infection or inflammation such that the number of lymphocytes present in a given LN remains remarkably constant during adult life^[@R1]^. One possible reason that this set point evolved is to optimize the environment for lymphocyte survival as well as activation upon specific antigen encounter. Indeed, circulation through lymph nodes provides access to limited survival signals such as IL-7 that are required for cell survival^[@R2]^. In further support of this hypothesis are studies in which naïve T cells of known specificity were transferred at carefully titrated numbers into recipient animals prior to peptide immunization^[@R3]^. This work demonstrated that when the number of transferred cells exceeds physiological levels, the proliferative capacity of the donor cells was compromised. Thus, LN cell number must be precisely controlled to maintain immune homeostasis and maximize responsiveness upon immune challenge.

Although homeostatic control of T and B cell populations in the LNs is well-established, the impact that local lymphoid tissue inflammation may have on the systemic pool of lymphocytes is less clear. One consequence of infection or immunization-induced inflammation is transient enlargement of LNs draining the site of immune challenge. Factors contributing to LN hyperplasia include expansion of the lymphatic^[@R4]^, fibroblast reticular cell^[@R5]^ and arterial networks^[@R6],[@R7]^ that collectively enhance leukocyte entry into the draining LN as well as proliferative effector cell expansion and retention^[@R8]^. In experiments examining the primary Th2-driven immune response to *Heligmosomoides polygrus* (*Hp*), a strictly enteric helminth parasite, we observed dramatic and sustained enlargement of the mesenteric lymph nodes (mesLN), the primary site of adaptive immune cell activation following infection. In addition to robust expansion of CD4^+^ T and B effector cells, we unexpectedly observed a significant and persistent accumulation of naïve T and B cells in the inflamed mesLN. Subsequent experiments were performed to understand 1) the relevance of naïve lymphocyte accumulation to the primary effector cell response 2) the mechanisms underlying this accumulation and 3) its impact on the systemic distribution of the naïve lymphocyte pool and response to secondary challenge.

RESULTS {#S2}
=======

Naïve lymphocytes accumulate in the Th2 reactive mesenteric lymph nodes following enteric helminth infection {#S3}
------------------------------------------------------------------------------------------------------------

Infection of mice with the enteric helminth parasite (*Hp)* results in a robust Th2 and Type 2 humoral response initiated in the mesLN^[@R9],[@R10]^. This response results in a striking enlargement of the mesLN by 2 weeks post-infection and a dramatic increase in mesLN weight and total lymphocyte number (hyperplasia) as well as morphological changes due to a robust humoral immune response ([Figure 1A-C](#F1){ref-type="fig"}). *Hp*-induced mesLN hyperplasia persisted through the chronic stage of infection (i.e. 6 weeks), yet was reduced if the parasite was eliminated using anti-helminthics at 2 weeks post-infection ([Figure 1C, D](#F1){ref-type="fig"}). Further characterization of lymphocyte subsets in the Th2 reactive mesLN over the course of infection indicated that the total number of CD4^+^ and CD8^+^ T cells significantly increased between 1 and 4 weeks post-infection with the CD19^+^ B cell pool increasing with slightly more rapid kinetics ([Figure 1E](#F1){ref-type="fig"}). In addition to an expected increase in the number of CD44^hi^CD62L^lo^ effector lymphocytes ([Figure 1F](#F1){ref-type="fig"}, see [supplemental Figure 1A-C](#SD2){ref-type="supplementary-material"} for gating), we also noticed an unexpected increase in the number of CD44^lo^CD62L^hi^ naive phenotype lymphocytes. In fact, the majority of the T and B lymphocytes present in the inflamed mesLN expressed a naïve phenotype ([Figure 1G](#F1){ref-type="fig"}). These results demonstrate that naïve T and B cell accumulation occur within the Th2 reactive LN following helminth infection.

The accumulation of naïve lymphocytes is driven by an increased homeostatic set-point {#S4}
-------------------------------------------------------------------------------------

Th2 differentiation and IL-4 production is critical for protective immunity to *Hp* infection^[@R11]^. IL-4 cytokine reporter (4get) mice in which GFP identifies IL-4 expressing cells are a sensitive ex vivo readout for Th2 differentiation^[@R12]^. We have previously shown that the number of IL-4/GFP^+^ effector CD4 T cells in the mesLN begins to increase within the first 5 days of *Hp* infection and continues to expand over time, reaching its peak between 2-4 weeks post-infection^[@R13]^. In contrast, naïve T cells began to accumulate in the Th2 reactive mesLN only after 7 days post-infection ([Figure 1G](#F1){ref-type="fig"}). To determine whether this accumulation contributed to the IL-4^+^ effector T cell response, 4get mice were treated with anti-CD62L mAb between days 7 and 14 post-infection to inhibit naïve lymphocyte entry into the mesLN^[@R14]^. Analysis on day 14 post-infection revealed a dramatic reduction in naïve T and B cell accumulation, as measured by a GFP^-^CD44^lo^ or IgD^+^CD44^lo^ phenotype (in lieu of CD62L), respectively, in the mesLN of infected mice ([Figure 2A](#F2){ref-type="fig"}); however, no significant defect in the number of IL-4^+^ effector CD4 T cells was observed ([Figure 2B](#F2){ref-type="fig"}). To further determine whether the period between 1-2 weeks post-infection represented a critical phase for naïve T and B cell accumulation, some mice treated with anti-CD62L were examined 1 week after antibody treatment was terminated (i.e. day 21 post-infection). Release of the entry blockade after the second week of infection restored the number of naive T and B cells to isotype-treated control levels. However, again we did not observe any difference in the number of IL-4^+^ effector CD4 T cells at this time point ([Figure 2A, B](#F2){ref-type="fig"}). Collectively, these data indicated that the accumulation of naïve T cells in the reactive mesLN beginning one week after infection does not affect IL-4^+^ effector CD4 T cell response and that the reactive mesLN represents a sustained reservoir for naive lymphocytes due to an increased homeostatic set-point.

CD4^+^ T cell activation is required for naïve B lymphocyte accumulation {#S5}
------------------------------------------------------------------------

A previous study using subcutaneous immunization with antigen in Th1-polarizing CFA adjuvant demonstrated that B cells were important for LN enlargement^[@R4]^. To determine whether B cells also contribute to naïve T cell accumulation in a Th2-dominanted immune response, BALB/c or B cell-deficient JhD mice were infected with *Hp* and naïve T cells were enumerated in the mesLN 2 weeks later. In contrast to CFA immunization (Angeli et al., 2006), the number of naïve T cells was not decreased in the absence of B cells, but in fact increased, compared to WT controls suggesting a potential regulatory role for B lymphocytes in naïve T cell accumulation ([Figure 3A](#F3){ref-type="fig"}). Using a model of viral infection, Iwasaki and colleagues showed that innate immune mechanisms contributed to transient LN enlargement and naïve T cell accumulation within 48 hours of immune challenge^[@R6]^. In the case of *Hp* infection, however, we did not observe naïve T lymphocyte accumulation prior to day 7 post-infection ([Figure 1A](#F1){ref-type="fig"}) suggesting that the adaptive immune response may play a more dominant role. Using CD19^+^IgD^+^CD44^lo^ B cells as a readout for naïve lymphocyte accumulation, BALB/c, TCRα -deficient BALB/c and CD4 T cell-depleted BALB/c mice were infected with *Hp* and the number of naïve B cells was determined 2 weeks later. In contrast to B cell-deficient mice, infected animals that lack αβ T cells or were depleted of CD4^+^ cells failed to accumulate naïve B cells in their draining mesLNs ([Figure 3B, C](#F3){ref-type="fig"}). MesLN from *Hp*-infected DO11.10 mice containing a monoclonal population of CD4^+^ T cells specific for chicken ovalbumin also failed to accumulate naïve B cells ([Figure 3D](#F3){ref-type="fig"}), indicating that not just CD4^+^ T cells per se, but activation of this population by cognate antigen was required.

Lymphotoxin-β receptor signaling is required for naïve lymphocyte accumulation {#S6}
------------------------------------------------------------------------------

Because naïve lymphocyte accumulation required CD4^+^ T cell activation, but was not required for the increase in IL-4^+^ effector CD4 T cells after 1 week of infection, we sought to identify factors that regulated naïve T cell accumulation independent of the Th2 response. These events could not be separated in mice unable to receive IL-4 signals because both naïve T cell accumulation and, consistent with our previous studies^[@R15]^, the Th2 response was compromised following *Hp* infection of IL-4Rα KO 4get mice ([Figure 4A,B](#F4){ref-type="fig"}). In addition, experiments using mice deficient in TNFα or Type I interferon receptor (IFNAR) signals, two pathways previously shown to promote LN hyperplasia^[@R16],[@R17]^, demonstrated that these factors were not only dispensable for naïve lymphocyte accumulation following *Hp* infection but may actually exert regulatory effects, at least on T cell accumulation ([Figure 4C, D](#F4){ref-type="fig"} and [supplemental Figure 3A, B](#SD2){ref-type="supplementary-material"}).

Lymphotoxin β receptor (LTβR) has been previously shown to play a role in Type 2 immunity following *Hp* infection and mice deficient in the LTβR ligands experience compromised LN hyperplasia following subcutaneous immunization with CFA^[@R18]-[@R20]^. However, in these studies LTβR signals were inhibited at the time of infection or immunization, potentially compromising initial dendritic cell (DC)-dependent T cell recruitment to the mesLN^[@R21]^. Since naive T lymphocytes do not accumulate prior to establishment of a robust Th2 response (i.e. 1 week after *Hp* infection; [Figure 1](#F1){ref-type="fig"}), we blocked LT signaling by administering LTβR-Ig on days 7 and 10 and assessed naïve T cell accumulation and the IL-4^+^ effector CD4 T cell response on day 14. Compared to control animals, naïve T and B cells failed to accumulate in the mesLN of LTβR-Ig-treated mice ([Figure 4E](#F4){ref-type="fig"}). Importantly, the treatment resulted only in a subtle, albeit significant, reduction in the number of IL-4/GFP^+^ expressing CD4^+^ T cells ([Figure 4F](#F4){ref-type="fig"}). These results were most likely not due to a change in lymphocyte survival as the frequency of active Caspase-3^+^ cells (a marker of apoptosis) was not different between the groups ([supplemental Figure 3C-E](#SD2){ref-type="supplementary-material"}).

A previous report described an important role for LTβ production by B cells in LN hyperplasia and remodeling during *Hp* infection^[@R20]^. While we found that LT signals were also important for naïve T cell accumulation, our results indicated that B cells were not required suggesting that other cellular sources of LTβR ligands contribute to this process. To examine whether other LN cell populations express ligands for LTβR including LTαβ and LIGHT, DCs, B cells and CD4^+^ T cells were sorted from the mesLN of *Hp*-infected mice and *Lta*, *Ltb* and *Tnfsf14* (encoding for LIGHT) were measured by qRT-PCR. Although both *Lta* and *Ltb* were expressed at high levels by all immune cell subsets examined (data not shown), their relative difference compared to B cells was small ([Figure 4G](#F4){ref-type="fig"}). By contrast, both DCs and CD4^+^ T cells expressed high levels of *Tnfsf14* mRNA compared to B cells ([Figure 4G](#F4){ref-type="fig"}). Collectively, these data indicate that LTβR-dependent signals, possibly from multiple immune cell subsets, orchestrate the accumulation of naïve lymphocytes in the inflamed mesLN independent of its effects on initial Th2 differentiation or cell survival following helminth infection.

Loss of naïve lymphocytes from non-draining LN during *Hp* infection {#S7}
--------------------------------------------------------------------

The striking and persistent accumulation of naïve lymphocytes in the mesLN of *Hp*-infected animals prompted us to identify the site(s) from where these cells may derive. Although the thymus generates new naive T lymphocytes and the spleen contains a large number of naïve T and B cells that could potentially be recruited to inflamed sites, neither thymectomy nor splenectomy of adult mice prior to infection affected the accumulation of naïve T and B cells (unpublished observations). However, the number of lymphocytes and naïve T and B cell subsets in non-draining LN (e.g. inguinal, axillary, and brachial LNs) were significantly reduced at 2 weeks after *Hp* infection compared to uninfected controls ([Figure 5A](#F5){ref-type="fig"}). To test whether the naive lymphocyte redistribution occurred in an antigen-independent manner, OVA-specific CD4^+^ T cells were purified from DO11.10 mice and transferred into Thy1 congenic uninfected mice or mice infected with *Hp* 11 days prior. One hour after transfer, ten-fold more donor KJ1-26^+^ DO11.10 T cells were found in the mesLN of *Hp* infected mice compared to uninfected controls (as determine by FACS; [Figure 5B](#F5){ref-type="fig"}). Consistent with the infection-induced redistribution of the polyclonal naïve lymphocyte population from the peripheral LNs, there were significantly fewer donor DO11.10 cells in the peripheral LNs of infected mice compared to uninfected controls ([Figure 5B](#F5){ref-type="fig"}). The full extent of the systemic redistribution was revealed by comparing the accumulation of donor T cells in the mesLN relative to the skin-draining LN in the same animal ([Figure 5C](#F5){ref-type="fig"}). These data indicate that the systemic naïve lymphocyte pool can be redistributed in an antigen-independent manner following an enteric helminth infection.

*Hp* infection compromises immunity to heterologous challenge at peripheral sites {#S8}
---------------------------------------------------------------------------------

Landmark studies by Moon et al. demonstrated that the starting number of naïve lymphocytes specific for a given antigen predicts the magnitude of the primary adaptive immune response following immunization with relevant peptide^[@R22]^. Because helminth infection effectively decreased the naïve lymphocyte number in non-draining LNs, we reasoned that the magnitude of the immune response to heterologous challenge at peripheral sites might be compromised in helminth-infected mice. To test this hypothesis, we employed several distinct methods of heterologous challenge to measure the antigen-specific response at peripheral sites of helminth-infected mice. First, at 2 weeks post-infection with *Hp*, mice were immunized with the T-dependent antigen 4-hydroxy-3-nitrophenylacetyl (NP)-KLH in alum and ten days after immunization, the frequency and number of NP-specific B cells in the skin-draining LN was determined. Comparing immunized mice with or without concurrent *Hp* infection, the frequency of class-switched IgD^-^ NP-specific B cells was similar between groups suggesting that activation of antigen-specific B cells on a per cell basis was not compromised ([Figure 6A](#F6){ref-type="fig"} and [supplemental Figure 2](#SD2){ref-type="supplementary-material"}). In contrast, the absolute number of NP-specific B cells in immunized mice infected with *Hp* was significantly decreased compared to uninfected controls ([Figure 6B](#F6){ref-type="fig"}). Concomitantly, serum titers of NP-specific IgG were decreased in helminth-infected mice compared to helminth-naïve animals ([Figure 6C](#F6){ref-type="fig"}). Similar differences in antigen-specific IgG titers were obtained using Prevnar13^®^, a clinically relevant pneumococcal vaccine formulation ([Figure 6D](#F6){ref-type="fig"}). To examine whether helminth infection also compromised immunity to heterologous infection at a distinct tissue site, *Hp*-infected or naïve mice were infected with influenza A virus (IAV)^[@R23]^. Seven days after IAV infection (day 21 post-*Hp* infection), the lung-draining mediastinal LNs were visibly smaller in helminth-infected mice compared to controls (unpublished observations) and this corresponded with a lower number of total lymphocytes ([Figure 6E](#F6){ref-type="fig"}). In addition, the number of IAV-specific CD8^+^ T effector cells in the mediastinal LNs was decreased in helminth-infected mice and was associated with increased viral burden in lungs compared to control animals ([Figure 6F, G](#F6){ref-type="fig"}). Collectively, these results suggest that helminth infection-induced systemic redistribution of naïve lymphocytes compromises the magnitude of the immune response to heterologous immune challenge and reduced pathogen clearance at distinct barrier sites.

DISCUSSION {#S9}
==========

Helminth infections almost universally elicit Th2 responses that limit worm burden, promote tissue repair and, in some cases, confer protection from re-infection^[@R9]^. However, an excessive Th2 response can be detrimental to the host leading to immunopathology^[@R24]^ and reduced fitness against other infectious agents^[@R25]-[@R27]^. Our results reveal another previously unknown consequence of enteric helminth infection, namely the systemic and sustained redistribution of the naïve lymphocyte pool away from peripheral LN into the mesLN resulting in compromised immune responses to heterologous peripheral challenge and increased susceptibility to infection. Although helminths including *Hp* produce immunosuppressive factors^[@R28]^, we did not find a change in the frequency of the antigen-specific response in the lymph nodes draining peripheral sites of immunized mice previously infected with *Hp* compared to uninfected controls suggesting a largely unimpeded priming of the heterologous immune response. However, we did observe a significant decrease in the magnitude of T and B effector cell response in three separate antigen-specific models of heterologous challenge. These data argue against direct immunosuppression by helminth-derived factors and instead suggests that an accumulation of naïve lymphocytes in the reactive mesLN compromised the availability of lymphocytes in peripheral lymph nodes and subsequent antigen encounter and activation. Surprisingly, the redistribution and accumulation of naïve lymphocytes in the mesLN of helminth-infected animals was not required to support the effector T cell response. The beneficial function that naïve T lymphocyte accumulation may have on host immunity to helminth infection has yet to be determined. It is tempting to speculate that the increased number of naive T cells in the mesLN enhances the ability to respond to additional local immune challenges that might be brought about by the compromised barrier integrity as a consequence of helminth-induced tissue damage^[@R29]^. However, as discussed below, the mechanisms driving naïve T cell accumulation may also contribute to the anti-helminth humoral immune response.

Our results indicated that naïve lymphocyte accumulation in the inflamed mesLN required both CD4^+^ T cell activation and LTβR-dependent signals. Harris and colleagues recently demonstrated that LTβ production by B cells acts on CCL19-producing stromal cell populations to reorganize the lymph node structure, induce lymph node hyperplasia and promote *Hp*-specific antibody responses^[@R20]^. Importantly, they found IL-4 to promote LTβ production by B cells in vitro and IL-4 receptor signaling to be critical for mesLN restructuring in vivo. Consistent with these results, we also found expression of IL-4Rα contributes to naïve lymphocyte accumulation and lymph node hyperplasia. Our previous work demonstrated that the dominant source of IL-4 in the reactive mesLN of *Hp*-infected mice are CD4^+^ T follicular helper (Tfh) cells^[@R15]^. These studies collectively suggest that, under normal conditions, early IL-4 secretion by Tfh cells promotes LTβ production by follicular B cells that expands LTβR-expressing stromal cells to reorganize the LN architecture. Indeed, we have found IL-4 to be produced by CD4^+^ T cells as early as 5 days post-*Hp* infection, a time point that precedes a detectable germinal center B cell and antibody response^[@R30]^. These results are consistent with another study that also found LTβ production by B cells promotes Th2 responses following *Hp* infection^[@R18]^. However, we also found B cells to be dispensable for naïve T cell accumulation indicating an additional source of LTβR ligand that compensates for B cell production of LTβ. As our data show that DCs and CD4^+^ T cells express high levels of *Tnfsf14* mRNA (the gene encoding for LIGHT, an alternate LTβR ligand) compared to B cells and that LIGHT has been previously shown to be important for LN hypertrophy following immunization^[@R19]^, we suggest that DCs and/or T cells can also directly contribute to enhancing naïve lymphocyte accumulation in reactive lymph nodes. Based on our results and those of others, we speculate that following DC-dependent CD4^+^ T cell priming, T cells produce LTβR ligands or elicit production of these factors by DCs facilitating the accumulation of naïve lymphocytes in the inflamed mesLN. Subsequent IL-4 production by developing Tfh cells stimulates B cell production of LTβ that along with LIGHT promotes stromal cell activation and mobilization. This intercellular IL-4-LTβ signaling network then feeds forward to help position T and B cells to interact in a highly efficient manner to drive the humoral immune response and generate protective antibodies against the intestinal parasite. However, this comes at the cost of compromising immunity to subsequent infection at peripheral sites. Consistent with our studies, deworming individuals prior to BCG vaccination enhances the magnitude of the *M. tuberculosis*-specific T cell response^[@R31]^. Our results provide one potential explanation for this clinical benefit and may inform vaccination strategies in regions of the world where helminth infections are endemic.

MATERIAL AND METHODS {#S10}
====================

Animals {#S11}
-------

BALB/c, 4get^[@R12]^, 4get x *Il4ra* KO, *Tcra* KO, JhD and OVA-TCR transgenic DO11.10 mice all on a BALB/c background and *Ifnar* KO and *Tnfa* KO mice on a C57BL/6 background were bred and kept under specific pathogen-free conditions and used at 8--12 wk of age. All experiments were performed under Institutional Animal Care and Use Committee-approved protocols at the Trudeau Institute and McGill University.

Infections and immunizations {#S12}
----------------------------

Animals were infected by gavage with 200 third stage larvae of *Heligmosomoides polygyrus* as described^[@R10]^. In some experiments, adult *Hp* parasites were eliminated by two oral administrations of 100 mg/kg pyrantel pamoate (Columbia Laboratories, Ottawa, Ontario) delivered 2 d apart. For heterologous challenge experiments, some mice were immunized in the footpad with 100μg of NP-KLH (Biosearch technologies) precipitated in alum (Imject 77161, ThermoScientific) or intramuscularly with 0.5μg Prevnar13^®^ (Pfizer). Influenza infections were performed intranasally with a sublethal dose (50 PFU) of H1N1 strain A/Puerto Rico/8/34 in a 25μl volume. Virus was propagated and isolated from Madin-Darby canine kidney (MDCK) cells and titrated with standard plaque assay in MDCK cells^[@R23]^.

Antibody and LTβR-Ig treatments {#S13}
-------------------------------

At specified time points following *Hp* infection, some mice were i.p. injected with either 100μg anti-CD62L (MEL14) or rat IgG2a isotype control every other day for the indicated period or 150μg LTβR-Ig or control reagent (provided by Biogen) on days 7 and 10 post-*Hp* infection^[@R32]^. Anti-CD4 (GK1.5, 500μg/mouse) or rat IgG2b isotype control was given i.p. one day before infection and CD4^+^ T cell depletion after 2 weeks was still greater than 98% (as determined by staining for TCRβ, CD8α and anti-CD4 (RM4-4)).

T cell transfers {#S14}
----------------

CD4^+^ T cells were FACS sorted from the lymph nodes of Thy1.2^+^ DO11.10 mice and 5×10^[@R5]^ cells were transferred i.v. into naive or day 11 *Hp*-infected Thy1.1^+^ recipients. One hour later, the number of donor CD4^+^ T cells present in the mesLN and pooled non-draining inguinal, axillary and brachial skin-draining LN was assessed by flow cytometry.

Flow cytometry {#S15}
--------------

Single cell suspensions were prepared from the mesenteric or non-draining lymph nodes, stained and analyzed as described^[@R10]^. The following mAbs were used for flow cytometry; clone designations are given in parenthesis: CD4 (RM4-5, RM4-4), CD8α (53-6.7), CD19 (1D3), B220 (RA3-6B2), CD11c (N418), MHCII (M5/114.15.2), CD62L (MEL-14), CD44 (IM7), IgD (11-26c), DO11.10 TCR (KJ1-26), Thy1.1 (OX7), Thy1.2 (53-2.1) (BD biosciences, eBiosciences or Biolegend). NP was conjugated to APC as reported^[@R33]^ and used in standard antibody staining procedures for antigen-specific B cell detection. Influenza-specific CD8^+^ T cells were identified with NP (ASNENMETM)-loaded H-2D^b^ tetramers conjugated to APC (1:600 dilution; National Institutes of Health Tetramer Core Facility, Emory University Vaccine Center). Propidium iodide or fixable viability dye (eBiosciences) was used to eliminate dead cells from analysis. Staining for intracellular active Caspase-3 (C92-605) was performed using Cytofix/Cytoperm reagants as suggested by the manufacturer (BD Biosciences). Samples were acquired on a FACS Canto II or LSR Fortessa (BD Biosciences) and analyzed with FlowJo software (Tree Star, Inc.).

ELISA {#S16}
-----

Serotype 3 *Streptococcus pneumoniae* polysaccharide-specific IgG was detected in serum 4-5 weeks following i.m. challenge by polysaccharide-specific ELISA. Briefly, 96 well plates were coated with purified polysaccharide (ATSS) overnight, washed and serum dilutions were applied. HRP anti-mouse IgG detecting antibody (Southern Biotech) was applied, developed with ABTS buffer and read on a Molecular Devices SPECTRAmax Plus 384 at 405nm. NP-specific IgG was detected in serum by heteroclitic NIP (4-hydroxy-5-iodo-3-nitrophenyl)-specific ELISA as described^[@R33]^. Protocol was identical to polysaccharide ELISA except plates were coated with NIP(11)-OVAL and an IgG anti-NP standard (clone PeVch 1/λ1, BioXcell) was used.

qRT-PCR {#S17}
-------

mesLN cells were sorted into the populations described in [Figure 4](#F4){ref-type="fig"} using a FACS Aria III prior to RNA extraction. mRNA was extracted using Qiagen RNeasy Micro Kit and cDNA samples were prepared as previously described^[@R15]^. Custom primer sequences were generated using Primer3 software for the following genes: *Lta,* Fwd: CAGCAAGCAGAACTCACTGC, Rev: CACTGAGGAGAGGCACATGG; *Ltb,* Fwd: ACCTCATAGGCGCTTGGATG, Rev: ACGCTTCTTCTTGGCTCGC; *Tnfsf14*, Fwd: GCATGGAGAGTGTGGTACAGC and Rev: TGTCTCCAAGACGTTGATGC and *Hprt*, Fwd: AGGACCTCTCGAAGTGTTGG and Rev: AACTTGCGCTCATCTTAGGC. Quantitative real-time RT-PCR was performed by sybr green detection using the Biorad CFX96^TM^ Real-Time System and software. Fold expression was calculated using the ΔΔ^CT^ method and *Hprt* as a reference gene.

Confocal fluorescence microscopy {#S18}
--------------------------------

Frozen mesLN cut into 7 μm sections were embedded in optimum cutting temperature compound and labeled with anti-B220 (RA3-6B2), anti-GL7 (GL7) and anti-CD4 (RM4-5) from BD biosciences. Fluorescent images were obtained with a TCS SP5 confocal microscope and 'stitched' high-resolution whole LN confocal images were obtained using LAS AF 2.2.1 software (Leica).

Statistical analysis {#S19}
--------------------

GraphPad Prism (version 5) was used for statistical analysis. Data sets were compared by unpaired, two-tailed Student's or Mann-Whitney *t* test with the exception of [Figure 1C](#F1){ref-type="fig"} and [4G](#F4){ref-type="fig"} in which a one-way ANOVA was used followed by a Tukey's post-hoc analysis. Data are represented as mean ± SEM if not indicated otherwise. ns, not significant; \*, *p*\<0.05; \*\*, *p*\<0.01; \*\*\*, *p*\<0.001.
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![Naïve lymphocytes accumulate in the Th2 reactive mesLN following intestinal helminth infection\
BALB/c mice were infected with *Hp* or remained naive and the mesLN were collected at the indicated time points. (A) Representative image of mesLN from naïve and 2 wk *Hp*-infected animals. (B) Confocal immunofluorescent images of uninfected and 2 wk *Hp* infected mesLN. B220, white; CD4, red; GL7, green. Bar, 500 μm. (C) MesLN weight from naïve and *Hp* infected animals. Some mice received anti-helminthics at 2 weeks post-*Hp* infection; p.i., post-infection. (D) Number of total or (E) CD4^+^, CD8^+^, and CD19^+^ lymphocytes in the mesLN at the indicated times after infection. (F) Number of effector and (G) naïve phenotype CD4^+^, CD8^+^ and CD19^+^ lymphocytes at the indicated time points after infection. Each data point shows the mean of 4-5 individual mice and error bars indicate the SEM. Data are representative of at least three independent experiments. \*p \< .05, \*\*p \< .01, \*\*\*p \< .001.](nihms834155f1){#F1}

![Delayed naive lymphocyte accumulation is dispensable for IL-4^+^ effector CD4 T cell differentiation\
BALB/c 4get mice were infected with *Hp* or remained uninfected and were treated every other day with anti-CD62L (MEL-14) or rIgG2a isotype control during the indicated period. MesLN were analyzed on day 14 or 21 post-infection as specified in parentheses. (A) Number of naïve phenotype CD4^+^ and CD19^+^ lymphocytes. (B) Number of GFP^+^IL-4^+^ effector CD4 T cells. Each data point shows the mean of 4-5 individual mice and error bars indicate the SEM. Data are representative of two independent experiments.](nihms834155f2){#F2}

![CD4^+^ T cell activation is required for naïve B lymphocyte accumulation\
(A) B cell deficient JhD mice and BALB/c WT controls were infected with *Hp* or remained uninfected and the number of naïve phenotype CD4^+^ T cells in the mesLN was analyzed 2 wk later. (B) T cell deficient TCRα KO mice and BALB/c WT controls were infected with *Hp* or remained naïve and the number of naïve phenotype CD19^+^ B cells in the mesLN was analyzed 2 wk later. (C) BALB/c mice were treated with anti-CD4 or rIgG2b isotype control and infected with *Hp* one day later. The number of naïve phenotype CD19^+^ B cells in the mesLN was determined at 2 wk post-infection. (D) DO11.10 TCR transgenic mice and BALB/c WT controls were infected with *Hp* and the number of naïve phenotype CD19^+^ B cells in the mesLN was determined at 2 wk post-infection. Each data point shows the mean of 3-5 individual mice and error bars indicate the SEM. Data are representative of at least two independent experiments. ns, not significant; \*p \< .05, \*\*\*p \< .001.](nihms834155f3){#F3}

![Lymphotoxin-β receptor signaling is required for naïve lymphocyte accumulation\
(A, B) IL-4Rα deficient and WT BALB/c 4get mice were infected with *Hp* or remained naïve and the number of naïve (A) or IL-4/GFP^+^ effector (B) CD4^+^ T cells in the mesLN was analyzed at 2 wk post-infection. IFNAR KO mice (C) or TNF-α KO mice (D) as well as C57BL/6 WT controls were infected with *Hp* or remained naive. The number of naive phenotype CD4^+^ T cells in the mesLN was determined 2 wk later. (E, F) BALB/c 4get mice were infected with *Hp* and LTβR-Ig or control IgG was administered i.p. on days 7 and 10 after infection. The number of naive CD4^+^ T and CD19^+^ B cells (E) or effector phenotype CD4^+^ T cells (F) in the mesLN was analyzed at 2 wk post-infection. (G) B220^+^CD4^-^ B cells, CD11c^+^MHCII^+^ and CD4^+^B220^-^ T cells were sorted from the mesLN of 2 week *Hp*-infected mice and mRNA from each population was assessed by qRT-PCR for the indicated transcripts. Each group shows the mean of 8 individual mice and error bars indicate the SEM. Data are representative of at least two independent experiments. ns, not significant; \*p \< .05, \*\*p \< .01 \*\*\*p \< .001.](nihms834155f4){#F4}

![Intestinal helminth infection results in the systemic and sustained redistribution of the naive lymphocyte pool\
(A) BALB/c or 4get BALB/c mice were infected with *Hp* and the number of total lymphocytes and naive phenotype CD4^+^ T and CD19^+^ B cells in the mesLN (left Y axis) and the pooled non-draining inguinal, axillary and brachial LN (ndLN) (right Y axis) were determined at the indicated time points. Each data point shows the mean of 3-5 individual mice and error bars indicate the SEM. Data are representative of at least two independent experiments. (B) OVA-specific CD4^+^ T cells from Thy1.2^+^ DO11.10 mice were transferred into uninfected or day 11 *Hp* infected Thy1.1^+^ congenic mice. The number of Thy1.2^+^KJ1-26^+^ donor CD4^+^ T cells in the mesLN or the pooled non-draining inguinal, axillary and brachial LN (ndLN) was determined one hour later by flow cytometry. (C) The relative recruitment of DO11.10 donor cells into the mesLN relative to the ndLN was calculated based on the total numbers determined in B. Scatter plots in B and C show data from individual mice. Data are representative of two independent experiments with 3 mice per group.](nihms834155f5){#F5}

![Intestinal helminth compromises immunity to heterologous challenge at peripheral sites\
C57BL/6 mice were infected with *Hp* or remained naive. Two weeks later the animals were heterologously challenged. (A-C) One week after footpad immunization with NP-KLH in alum, the frequency (A) and number (B) of IgD^-^ isotype switched NP-specific B cells in the draining popliteal LNs were determined by flow cytometry. (C) Serum anti-NP IgG titers at day 21 after NP-KLH immunization. (D) *Hp*-infected or naïve mice were immunized i.m. with the anti-pneumococcal vaccine formulation Prevnar13^®^ and anti-*S. pneumoniae* polysaccharide IgG titers were determined 4-5 weeks later. (E, F) Number of total (E) or influenza (IAV)-specific CD8^+^ effector T lymphocytes (F) from the mediastinal LN of *Hp*-infected or helminth-naïve animals 7 days after i.n. infection with 50 pfu IAV. (G) Pulmonary viral load (pfu) was determined at day 7 post-IAV infection. Data shown is pooled from two independent experiments containing a total of 14-15 mice/group. Error bars indicate the SEM. ns, not significant; \*p \< .05, \*\*p \< .01 \*\*\*p \< .001.](nihms834155f6){#F6}
